Citations

Showing 10 of 107969 citations.

DCTN1Mutations and Progressive Supranuclear Palsy–Like Phenotype
Fujioka, Shinsuke , Tacik, Paweł , Wszołek, Zbigniew K.

Mayo Clinic

JAMA Neurology | May 12, 2014 | Volume: 71 | Issue: 5 | Pages: 655

10.1001/jamaneurol.2014.227 | PMID 24818686 Get It

Faculty Opinions recommendation of Targeting and tracing of specific DNA sequences with dTALEs in living cells.
Ekker, Stephen C.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | May 12, 2014 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718218620.793494255 Get It

Faculty Opinions recommendation of Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signaling.
Fernández-Zapico, Martín E.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | May 12, 2014 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718348656.793494314 Get It

Faculty Opinions recommendation of Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression.
Fernández-Zapico, Martín E.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | May 12, 2014 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718335485.793494316 Get It

Faculty Opinions recommendation of The human microbiome and surgical disease.
Chua, Heidi K, Chu, Daniel I.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | May 12, 2014 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718365566.793494527 Get It

Faculty Opinions recommendation of Transcranial amelioration of inflammation and cell death after brain injury.
Eyo, Ukpong B , Wu, Long‐Jun , Eyo, Ukpong B.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | May 12, 2014 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718201301.793494630 Get It

Tibiofemoral alignment in posterior stabilized total knee arthroplasty: Static alignment does not predict dynamic tibial plateau loading
Miller, Emily J. , Pagnano, Mark W. , Kaufman, Kenton R. , Kaufman, Kenton R

Mayo Clinic

Journal of Orthopaedic Research | May 12, 2014 | Volume: 32 | Issue: 8 | Pages: 1068-1074

10.1002/jor.22644 | PMID 24820681 Get It

ABSTRACTFor total knee arthroplasty (TKA), neutral mechanical alignment produces balanced static knee loading. Dynamically, knee loading is affected by more than limb static alignment. We compared static and dynamic knee loading following TKA. Fifteen TKA patients were evaluated pre‐operatively and 2 months and 2 years post‐operatively. Tibiofemoral angles and medial tibial plateau loading were calculated. Pre‐operatively, static medial load was greater for varus than valgus knees. Post‐operatively, no relationship existed between tibiofemoral angle and static medial plateau load. Pre‐operatively and post‐operatively, dynamic medial load was not dependent on tibiofemoral angle. While all patients achieved equal static plateau load distributions at 2 years, only 47% had dynamic medial load distributions of 50 ± 10%. Static tibiofemoral alignment alone does not predict dynamic tibial loading. © 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 32:???–???, 2014.
Time Trends in Glucocorticoid Use in Rheumatoid Arthritis: Results From a Population‐Based Inception Cohort, 1980–1994 Versus 1995–2007
Makol, Ashima , Davis, John M. , Crowson, Cynthia S. , Therneau, Terry M. , Gabriel, Sherine E., Matteson, Eric L. , Davis, John M , Makol, Ashima

Mayo Clinic

Arthritis Care & Research | May 12, 2014 | Volume: 66 | Issue: 10 | Pages: 1482-1488

10.1002/acr.22365 | PMID 24821680 Get It

ObjectiveTo examine trends in glucocorticoid (GC) use and dosing among patients diagnosed with rheumatoid arthritis (RA) over time.MethodsA population‐based inception cohort of RA patients diagnosed during 1980–2007 was followed longitudinally through their medical records until death, migration, or December 31, 2008. GC start and stop dates were collected, along with doses in prednisone equivalents.ResultsThe study population comprised 349 patients (68% women) diagnosed in 1980–1994 and 464 (69% women) diagnosed in 1995–2007, with a median followup of 15.3 and 5.7 years, respectively. A higher proportion of patients started GCs in their first year of disease in 1995–2007 (68% versus 36%; P < 0.001), but the starting dose (mean 8.7 versus 10.3 mg; P = 0.08) and cumulative dose in the first year of use (mean 1.8g [mean daily dose 4.9 mg] versus 2.1 gm [mean daily dose 5.8 mg]; P = 0.48) were not different. A higher proportion also discontinued GCs in their first year of disease in the 1995–2007 cohort (P < 0.001). These differences in GC initiation and discontinuation persisted throughout followup. Prevalence of GC use was higher in the 1995–2007 cohort for the first 3 years of disease.ConclusionMore patients are starting GCs early in their disease course now compared to previously, which is consistent with established treatment guidelines. A higher proportion are also discontinuing GCs, but the proportion of patients taking GCs at any given point of disease during the first 4 years is higher now than previously. Despite early addition of a disease‐modifying antirheumatic drug, some patients may not be able to discontinue GCs over the long term.
Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives
Alonso‐Coello, Pablo , Montori, Víctor M. , Díaz, Mireya , Dalmau, Gemma Mas , Díez, A.I. Fernández, Solà, Iván , Roura, Mercè, Souto, Juan Carlos , Oliver, Sven, Ruíz, Rafael Azuar , Coll‐Vinent, Blanca , Gich, Ignasi , Schünemann, Holger J. , Devereaux, P.J. , Guyatt, Gordon , Montori, Victor M , Schünemann, Holger J , Carlos Souto, Juan , Alonso-Coello, Pablo

Mayo Clinic

Health Expectations | May 12, 2014 | Volume: 18 | Issue: 6 | Pages: 2318-2327

10.1111/hex.12201 | PMID 24813058 Get It

AbstractBackgroundExploration of values and preferences in the context of anticoagulation therapy for atrial fibrillation (AF) remains limited. To better characterize the distribution of patient and physician values and preferences relevant to decisions regarding anticoagulation in patients with AF, we conducted interviews with patients at risk of developing AF and physicians who manage patients with AF.MethodsWe interviewed 96 outpatients and 96 physicians in a multicenter study and elicited the maximal increased risk of bleeding (threshold risk) that respondents would tolerate with warfarin vs. aspirin to achieve a reduction in three strokes in 100 patients over a 2‐year period. We used the probabilistic version of the threshold technique.ResultsThe median threshold risk for both patients and physicians was 10 additional bleeds (10 P = 0.7). In both groups, we observed large variability in the threshold number of bleeds, with wider variability in patients than clinicians [patient range: 0–100, physician range: 0–50]. We observed one cluster of patients and physicians who would tolerate <10 bleeds and another cluster of patients, but not physicians, who would accept more than 35.ConclusionsOur findings suggest wide variability in patient and physician values and preferences regarding the trade‐off between strokes and bleeds. Results suggest that in individual decision making, physician and patient values and preferences will often be discordant; this mandates tailoring treatment to the individual patient's preferences.